scholarly article | Q13442814 |
P50 | author | Yumei Feng | Q61731773 |
P2093 | author name string | Eric Lazartigues | |
Huijing Xia | |||
Peter J Hickman | |||
Teresa D Obr | |||
P2860 | cites work | Cloning and characterization of a secreted form of angiotensin-converting enzyme 2 | Q24304865 |
Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation | Q24311938 | ||
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases | Q28302418 | ||
Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure | Q30445660 | ||
Physiology of local renin-angiotensin systems. | Q34543927 | ||
Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla | Q34636700 | ||
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system | Q35567432 | ||
The CNS renin-angiotensin system | Q36429075 | ||
Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors. | Q36977221 | ||
Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats | Q37038877 | ||
Angiotensin-converting enzyme 2 in the brain: properties and future directions | Q37155907 | ||
Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats | Q37247541 | ||
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. | Q37352071 | ||
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. | Q41621710 | ||
Differential baroreceptor reflex modulation by centrally infused angiotensin peptides | Q42462109 | ||
Participation of AT1 and AT2 receptor subtypes in the tonic inhibitory modulation of baroreceptor reflex response by endogenous angiotensins at the nucleus tractus solitarii in the rat. | Q42544169 | ||
Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats | Q45101312 | ||
Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. | Q45214773 | ||
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. | Q46493539 | ||
Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii | Q46595087 | ||
Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats | Q46845265 | ||
Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats | Q48132473 | ||
Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats | Q48260358 | ||
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes | Q48350561 | ||
Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex | Q48365574 | ||
Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. | Q51363570 | ||
EFFECT OF AN ANTIHYPERTENSIVE DRUG ON BRAIN ANGIOTENSIN II LEVELS IN RENAL AND SPONTANEOUSLY HYPERTENSIVE RATS | Q58363962 | ||
Baroreceptor Reflex Sensitivity Estimated by the Sequence Technique is Reliable in Rats | Q60731517 | ||
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans | Q68487763 | ||
Neuro-cardiovascular regulation: from molecules to man. Introduction | Q74218884 | ||
Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery | Q80396565 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 210-216 | |
P577 | publication date | 2009-01-05 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice | |
P478 | volume | 53 |
Q24306614 | A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme |
Q92946509 | ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease |
Q50464178 | ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis |
Q100558878 | ACE2 mouse models: a toolbox for cardiovascular and pulmonary research |
Q35776364 | ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension |
Q40159156 | ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke |
Q33983361 | ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function |
Q34784864 | ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. |
Q90046431 | Activation of ADAM17 (A Disintegrin and Metalloprotease 17) on Glutamatergic Neurons Selectively Promotes Sympathoexcitation |
Q34158064 | Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction |
Q36501950 | Aldosterone acting through the central nervous system sensitizes angiotensin II-induced hypertension |
Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
Q34510691 | Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. |
Q34496676 | Angiotensin II receptors and drug discovery in cardiovascular disease |
Q28592286 | Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling |
Q35707198 | Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus. |
Q36825182 | Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence |
Q36020040 | Angiotensin converting enzyme 2: a new important player in the regulation of glycemia |
Q27022788 | Angiotensin peptides and nitric oxide in cardiovascular disease |
Q21710697 | Angiotensin type 1 receptor inhibition enhances the extinction of fear memory |
Q36267261 | Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice |
Q37440125 | Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology |
Q34479181 | Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy |
Q37079211 | Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure |
Q40143632 | Angiotensin-converting enzyme 2: a new target for neurogenic hypertension |
Q34978620 | Angiotensin-converting enzyme 2: central regulator for cardiovascular function |
Q35550937 | Angiotensin-converting enzyme 2: the first decade |
Q34423315 | Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. |
Q28081985 | Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease |
Q35138558 | Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress |
Q35776904 | Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension |
Q36031907 | Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension |
Q89107401 | Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats |
Q44894560 | Changes in gene expression in the frontal cortex of rats with pilocarpine-induced status epilepticus after sleep deprivation |
Q42031141 | Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction |
Q34535805 | Chronic sleep restriction during pregnancy--repercussion on cardiovascular and renal functioning of male offspring |
Q38781945 | Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension. |
Q46894741 | Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme |
Q33795353 | From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension |
Q35601958 | Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats |
Q36733839 | Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary |
Q95845011 | Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19 |
Q34731058 | Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension |
Q51747739 | Integrative Physiological Aspects of Brain RAS in Hypertension. |
Q43152722 | Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. |
Q37712468 | Neuronal over-expression of ACE2 protects brain from ischemia-induced damage |
Q37599394 | Not just angiotensinases: new roles for the angiotensin-converting enzymes |
Q34322162 | Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy |
Q36764034 | Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice |
Q38800189 | Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring |
Q33510142 | Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress |
Q90011350 | Role of brain renin angiotensin system in neurodegeneration: An update |
Q35812259 | Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment |
Q35543390 | Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays |
Q99633068 | The Actin Bundling Protein Fascin-1 as an ACE2-Accessory Protein |
Q92566054 | The Renin-Angiotensin System in the Central Nervous System and Its Role in Blood Pressure Regulation |
Q33742540 | The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure |
Q26823573 | The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges |
Q36114331 | α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17. |
Search more.